Oruka Therapeutics, Inc.Oruka Therapeutics, Inc.Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

No trades
See on Supercharts

Price target

43.170.000.00%
The 6 analysts offering 1 year price forecasts for ORKA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to ORKA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ORKA EPS for the last quarter is −1.46 USD despite the estimation of −0.40 USD. In the next quarter EPS is expected to reach −0.67 USD. Track more of Oruka Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Oruka Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Oruka Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ORKA price target is 43.17 USD with a max estimate of 49.00 USD and a min estimate of 40.00 USD. Check if this forecast comes true in a year, meanwhile watch Oruka Therapeutics, Inc. stock price chart and keep track of the current situation with ORKA news and stock market news.
We've gathered opinions of 7 analysts rating ORKA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.